The maker of the West’s first Covid-19 vaccine is building a new manufacturing alliance that could throw Europe and the rest of the world a lifeline amid a painful shortage of shots and a rebound in infections.
Read more here.
Wall Street Journal: BioNTech recruits rivals to boost Covid-19 vaccine production
A vial containing the Covid-19 vaccine by Pfizer-BioNTech and a syringe are seen on a table in the pharmacy of the vaccination center at the Robert Bosch hospital in Stuttgart, southern Germany, on February 12, 2021. (Photo by THOMAS KIENZLE / AFP)
